{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-26-001208","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2026-09-02T00:41:15+00:00","discovered_at":"2026-09-02T10:05:00.404834+00:00","generated_at":"2026-09-02T10:05:05.417372+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Starling Oncology director Brad Hively to step down as Vice Chairman, not seek re-election","bullets":["On Sept 1, 2026, Brad Hively notified Starling Oncology he will not stand for re-election at the 2027 annual meeting.","Hively remains a director until the annual meeting but immediately relinquishes Vice Chairman and committee roles.","Company states his decision is not due to any disagreement with operations, policies, or practices.","No replacement named; board composition change effective at 2027 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-26-001208","json":"https://secwatch.observer/filing/0001079973-26-001208.json","markdown":"https://secwatch.observer/filing/0001079973-26-001208.md","text":"https://secwatch.observer/filing/0001079973-26-001208.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/0001079973-26-001208-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/stln_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T10:05:05.417372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}